Thackray Helen M.
Insider CIK 1589725 · GLYC VP Clinical Development, CMO · IMGN Director · BCRX Chief R&D Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2025-03-31 | 2025-04-02 | 7,525 | $7.50 | $56.4K | 377,318 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2024-12-19 | 2024-12-23 | 260,950 | — | $0 | 260,950 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2024-12-19 | 2024-12-23 | 6,096 | $7.39 | $45.0K | 384,843 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-12-19 | 2024-12-23 | 125,950 | — | $0 | 390,939 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2024-12-14 | 2024-12-17 | 7,150 | $7.53 | $53.8K | 264,989 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2024-05-14 | 2024-05-15 | 30,000 | $5.86 | $175.8K | 272,139 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2024-03-31 | 2024-04-02 | 7,525 | $5.08 | $38.2K | 242,139 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 32,066 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,597 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 40,932 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 13,090 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer | 2024-02-12 | 2024-02-12 | 3,074 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award | 2023-12-29 | 2024-01-03 | 252 | $29.65 | $7.5K | 3,074 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2023-12-19 | 2023-12-20 | 5,580 | $6.05 | $33.8K | 249,664 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2023-12-14 | 2023-12-18 | 238,000 | — | $0 | 238,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-12-14 | 2023-12-18 | 51,000 | — | $0 | 258,275 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2023-12-14 | 2023-12-18 | 3,031 | $6.43 | $19.5K | 255,244 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award | 2023-09-29 | 2023-10-02 | 472 | $15.87 | $7.5K | 2,822 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award | 2023-06-30 | 2023-07-05 | 397 | $18.87 | $7.5K | 2,350 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 13,090 | — | $0 | 13,090 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 19,597 | — | $0 | 19,597 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2023-04-03 | 2023-04-05 | 7,000 | $8.29 | $58.0K | 207,275 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award | 2023-03-31 | 2023-04-04 | 1,953 | $3.84 | $7.5K | 1,953 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2022-12-19 | 2022-12-21 | 238,000 | — | $0 | 238,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-12-19 | 2022-12-21 | 81,000 | — | $0 | 214,275 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-12-15 | 2022-12-19 | 3,125 | $10.89 | $34.0K | 133,275 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 10,932 | — | $0 | 40,932 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 32,066 | $3.37 | $108.1K | 32,066 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-04-01 | 2022-04-04 | 7,600 | $16.20 | $123.1K | 136,400 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2021-12-14 | 2021-12-16 | 205,000 | — | $0 | 205,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-12-14 | 2021-12-16 | 44,000 | — | $0 | 144,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2021-09-22 | 2021-09-23 | 44,000 | $5.97 | $262.7K | 44,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2021-09-22 | 2021-09-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2021-03-31 | 2021-04-02 | 400,000 | — | $0 | 400,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-03-31 | 2021-04-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2021-01-20 | 2021-01-22 | 69,000 | — | $0 | 69,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award | 2021-01-20 | 2021-01-22 | 34,500 | — | $0 | 183,115 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-05-12 | 2020-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2020-01-22 | 2020-01-24 | 120,000 | — | $0 | 120,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-09-20 | 2019-09-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2019-01-17 | 2019-01-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2018-01-10 | 2018-01-12 | 75,000 | — | $0 | 75,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2017-12-08 | 2017-12-12 | 2,000 | $15.01 | $30.0K | 148,615 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2017-09-18 | 2017-09-18 | 2,000 | $13.00 | $26.0K | 150,615 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2017-05-25 | 2017-05-30 | 2,000 | $15.57 | $31.1K | 152,615 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2017-05-19 | 2017-05-22 | 2,000 | $12.14 | $24.3K | 154,615 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2017-01-04 | 2017-01-05 | 75,000 | — | $0 | 75,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2016-10-03 | 2016-10-04 | 100 | $7.01 | $701 | 156,615 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2016-10-03 | 2016-10-04 | 3,900 | $7.00 | $27.3K | 156,715 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2016-07-20 | 2016-07-21 | 2,000 | $8.00 | $16.0K | 160,615 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2016-07-06 | 2016-07-06 | 6,796 | $6.68 | $45.4K | 162,615 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2016-07-05 | 2016-07-06 | 10,136 | $7.01 | $71.1K | 169,411 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2016-07-01 | 2016-07-06 | 5,068 | $7.40 | $37.5K | 179,547 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2016-01-07 | 2016-01-11 | 71,000 | — | $0 | 71,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2015-01-08 | 2015-01-12 | 71,000 | — | $0 | 71,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2014-01-09 | 2014-01-13 | 112,692 | — | $0 | 112,692 | SEC↗ |